PGHH_AR_2020

Notes to Financial Statements for the year ended June 30, 2020 Annual Report 2019-20 111 Company Overview Board's Report MD&A CG Report Financial Statement Procter & Gamble Hygiene and Health Care Limited 27.4 Other segment information Depreciation and Impairment expense Capital Expenditure Year ended June 30, 2020 Year ended June 30, 2019 Year ended June 30, 2020 Year ended June 30, 2019 ` in lakhs ` in lakhs ` in lakhs ` in lakhs Health and hygiene 6 176 4 978 5 102 1 610 6 176 4 978 5 102 1 610 27.5 Revenue from major products The following is an analysis of the Company's revenue from continuing operations from its major products. Year ended June 30, 2020 Year ended June 30, 2019 ` in lakhs ` in lakhs Ointments and Creams 56 717 52 145 Cough Drops 32 029 29 516 Tablets 6 591 5 770 Other hygiene products 2 04 862 2 07 254 3 00 199 2 94 685 27.6 Geographical information The Company operates in two principal geographical areas - India (country of domicile) and outside India. The Company’s revenue from external customers by location of operations and information about its segment assets by location of assets are detailed below. Revenue from external customers Segment assets Year ended June 30, 2020 Year ended June 30, 2019 As at June 30, 2020 As at June 30, 2019 ` in lakhs ` in lakhs ` in lakhs ` in lakhs India 2 96 097 2 90 696 1 82 840 1 61 704 Outside India 4 102 3 989 ---- ---- 3 00 199 2 94 685 1 82 840 1 61 704 There is no transactions with single external customer which amounts to 10% or more of the Company’s revenue. 28 Earnings per share Year ended June 30, 2020 Year ended June 30, 2019 ` in lakhs ` in lakhs Basic and diluted earnings per share Total basic earnings per share (face value ` 10) 133.42 129.12 Total diluted earnings per share (face value ` 10) 133.42 129.12